Orbimed Advisors - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$95,643,000
+23.8%
2,207,3210.0%0.84%
-13.8%
Q3 2020$77,256,000
-21.0%
2,207,321
+20.7%
0.97%
-29.4%
Q2 2020$97,784,000
+44.8%
1,828,421
-3.9%
1.38%
+21.3%
Q1 2020$67,508,0001,902,6961.13%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders